77Indexed trials
canonical disease area
Substance Use Disorders
Intelligence
Substance Use Disorders intelligence: 77 indexed trials, 22 recruiting studies, 64 sponsors across 16 countries.
22Recruiting
64Sponsors
16Countries
Leading sponsors
Karolinska Institutet50 recruiting
New York State Psychiatric Institute20 recruiting
King's College London20 recruiting
Medical University of South Carolina20 recruiting
University of Michigan21 recruiting
Washington State University22 recruiting
National Institute on Alcohol Abuse and Alcoholism (NIAAA)21 recruiting
CHU de Reims21 recruiting
Beijing Normal University20 recruiting
Massachusetts General Hospital21 recruiting
Brigham and Women's Hospital11 recruiting
Centre Hospitalier Universitaire de Nīmes10 recruiting
Geographic activity
United States39trials
France6trials
Sweden6trials
United Kingdom4trials
China3trials
Switzerland3trials
Canada2trials
Netherlands1trials
South Korea1trials
Germany1trials
Belgium1trials
Brazil1trials
Leading interventions
Contingency Management2trials
Oxytocin2trials
Saline2trials
Acamprosate calcium1trials
Analysis of social functioning and social cognition processes1trials
Assessment only of alcohol and drug use.1trials
Analysis of executive functioning and of social cognition processes1trials
Bibliotherapy1trials
Briefer Self-help program, no guidance1trials
Buprenorphine patch and sublingual tablets1trials
CBT in group1trials
Benfotiamine1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.